Cancer concept (Photo: Shutterstock)

A bipartisan group of lawmakers last week reintroduced legislation to encourage innovative drug development targeting the most threatening infections, improve the appropriate use of antibiotics and ensure domestic availability of antibiotics when needed. The legislation is called the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.